Slide 1: MedCap Investor in Life Science – Company Presentation 2024
ap, ae i MEDCAP INVESTOR IN LIFE SCIENCE Company Presentation 2024
Slide 2: We create value in Life Science and contribute to improved quality of life
We create value in Life Science and contribute to improved quality of life 2
Slide 3: MedCap Snapshot
MedCap Snapshot Revenue, Business Areas Strategy million SEK Assistive MedTech Specialty Buy & Build Tech Pharma 1 789 A long-term home for well run Life Science companies EBITA margin Employees & locations EBITA CAGR 5 years 18.5% 534 29% 3
Slide 4: MedCap | An active investor in Life Science companies
MedCap | An active investor in Life Science companies Last Twelve Months, Q3 2024 Sales by Business Area Sales by Market RoW 4% Specialty Pharma Europe 25% Assistive 21% Tech 1 789 41% Sweden MSEK 50% Nordic MedTech 25% 34% 4
Slide 5: Our Model
Our Model Life Science Entrepreneurship Group Scale Sector focus Decentralized & local responsibility Scalable business areas Network of expertise Integrity of acquired brands Merger & Acquisitions Knowledge sharing Quick & agile, yet long-term mindset Governance – ESG Market insight Ambitious organ
Slide 6: Success factors
Success factors Solid markets Understanding the eco-systems Active ownership Non-cyclical Payor Prescriber End-user People & Management Demographic drivers Healthcare providers Distribution Business objectives Market nisches Regulation Sales & Marketing Performance management Market share potential
Slide 7: Examples of healthcare trends relevant to our business
Examples of healthcare trends relevant to our business Assistive Tech MedTech Specialty Pharma Consumer Health Health Economics & Regulations and Requirements Pharmaceutical shortages Screening, Diagnostic Digitalization, Connectivity, Use of data Home care, Telemedicine, Remote Monitoring Prevalenc
Slide 8: MedCap Business Areas
MedCap Business Areas Assistive Tech Med Tech Specialty Pharma Diagnostic ECG Probiotics, Components for Ultra clean air for Nutrition CDMO medical imaging infection control and Packaging Position Simplifying life for people Digitalizing work-flow Partner for contract Partner for carbon Improving co
Slide 9: Investment strategy
Investment strategy Scope What we look for Life Science Assistive | MedTech | Pharma Product / Software / Know-how Value creation journey Europe Clear value proposition Scalable business Add-ons globally M&A possibilities Market fundamentals ESG Innovative PEOPLE Small / Mid-size Businesses Entrepre
Slide 10: Acquisitions
Acquisitions Emfit, Add-on Toul Meditech & 21 Somna, 31 11 Unimedic, (Abilia) 26 SurgiCube, Sale of product Add-on 8 Handitek, Add-on (Abilia) Acquisition (D-droppar) 18 Miwana, Add-on Scandinavian (GEWA – changed 22 (Unimedic) Nutrients, Swedelift, name to Abilia) 27 Multi-Ply 32 1 IM-Medico, 5 GEW
Slide 11: Financial Targets
Financial Targets Annual EBITA growth Return on Equity Net debt / EBITDA >15% >20% <3x 11
Slide 12: Financial Targets
Financial Targets Annual EBITA growth Return on Equity Net debt / EBITDA [MSEK] >15% >20% <3x 400 25% 3 350 2.5 20% 300 2 250 15% 1.5 200 10% 1 150 5% 0.5 100 50 0 0% 2019 2020 2021 2022 2023 2024 0 -0.5 LTM 2019 2020 2021 2022 2023 2024 LTM -1 12
Slide 13: How we track our financial targets in our businesses
How we track our financial targets in our businesses Financial Objectives Key Metrics In Our Businesses Organic and acquisition driven sales growth (depending on maturity of business) >15% EBITA growth Profit margins Core Working Capital / Sales, Cash Conversion, EBITA / (Fixed assets & WC) Return o
Slide 14: Sales and EBITA rolling 12 months by quarter
Sales and EBITA rolling 12 months by quarter MSEK (Net sales) MSEK (EBITA) 1,900 Sales CAGR: 19% 400 1,800 EBITA CAGR: 29% 1740 1789 1,669 1,700 1,587 350 1,600 1,5 00 1,4 54 32 8 331 319 300 1,4 00 1,3 31 1,3 00 1,229 291 1,200 250 1,111 260 1,100 1,0 46 1,0 07 1,0 00 956 23 2 916 885 200 900 834 8
Slide 15: Why MedCap?
Why MedCap? 1 2 3 4 Sustainable Industry Profitable Growth Proven & Scalable Model Large & Growing Market Life Science industry Annual growth of 19% over Decentralized model – Fragmented market – many improves quality of life the last 5 years customer focused small and medium sized life responsibili
Slide 16: Thank You! Q&A
Thank You ! Q&A Anders Dahlberg Kristina Ekblad CEO CFO anders.dahlberg@medcap.se kristina.ekblad@medcap.se +46 704 269 262 +46 703 322 167 16